Bilirubin deficiency renders mice susceptible to hepatic steatosis in the absence of insulin resistance
Open Access
- 27 September 2021
- journal article
- research article
- Published by Elsevier in Redox Biology
- Vol. 47, 102152
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (1052616, 1111632)
- University of New South Wales
This publication has 60 references indexed in Scilit:
- Serum bilirubin levels are inversely associated with nonalcoholic fatty liver diseaseClinical and Molecular Hepatology, 2012
- Dissociation Between Intrahepatic Triglyceride Content and Insulin Resistance in Familial HypobetalipoproteinemiaGastroenterology, 2010
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisNew England Journal of Medicine, 2010
- High Total Bilirubin as a Protective Factor for Diabetes Mellitus: An Analysis of NHANES Data From 1999 - 2006Journal of Clinical Medicine Research, 2010
- PPARγ activation in adipocytes is sufficient for systemic insulin sensitizationProceedings of the National Academy of Sciences, 2009
- Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescentsAtherosclerosis, 2009
- A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overloadAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signalingProceedings of the National Academy of Sciences, 2008
- Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered miceJournal of Clinical Investigation, 2008
- Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic SyndromeHepatology, 2003